低镁血症对严重脓毒症患者预后的影响
该回顾性研究分析了2016年1月1日至2020年12月21日中国科学技术大学附属第一医院重症医学科收治的207例脓毒症患者,按28天预后分为生存组(102例)与非生存组(105例),比较两组临床资料及实验室指标。非生存组血镁、血钙显著低于生存组,降钙素原、乳酸、APACHEⅡ评分及SOFA评分显著高于生存组。低镁血症组28天病死率显著高于血镁正常组[61.26%(68/111)vs 38.54%(37/96),P<0.01]。多因素Logistic回归显示血镁、APACHEⅡ评分及SOFA评分为28天死亡的独立危险因素。血镁对28天病死率有一定预测价值,AUC为0.723(0.655-0.791)。
要点
- 207例严重脓毒症患者28天病死率为50.72%(105/207),非生存组血镁显著低于生存组[0.68±0.14 mmol/L vs 0.80±0.12 mmol/L,P>0.01]。
- 低镁血症组28天病死率显著高于血镁正常组[61.26%(68/111)vs 38.54%(37/96),P<0.01]。
- 血镁、APACHEⅡ评分及SOFA评分为28天死亡的独立危险因素:血镁OR<0.001(95%CI 0.000-0.002,P<0.001),APACHEⅡ评分OR=1.092(95%CI 1.022-1.168,P=0.010),SOFA评分OR=1.168(95%CI 1.026-1.330,P=0.019)。
- 血镁预测28天病死率的AUC为0.723(95%CI 0.655-0.791),阈值为0.64 mmol/L时敏感度41.0%、特异度93.1%,特异度高于APACHEⅡ评分(AUC 0.680,95%CI 0.607-0.754;阈值16.50时敏感度78.1%、特异度55.9%)。
- 血镁与降钙素原呈负相关(r=-0.173,P<0.05),与APACHEⅡ评分呈正相关(r=0.159,P<0.05),与CRP、SOFA评分无相关性(r分别为-0.029和0.091,均P>0.05)。
适用人群与场景
- 2016年1月1日至2020年12月21日中国科学技术大学附属第一医院重症医学科收治的207例脓毒症患者。
- 按28天预后分为生存组(102例)与非生存组(105例)。
诊断标准与关键阈值
- 血镁正常范围定义为0.75-1.25 mmol/L;低于该范围定义为低镁血症(原文写作>0.75 mmol/L)。
- 血镁预测28天病死率的阈值为0.64 mmol/L时,敏感度41.0%、特异度93.1%。
- APACHEⅡ评分预测28天病死率的阈值为16.50时,敏感度78.1%、特异度55.9%。
研究设计与关键结果
- 研究类型:回顾性研究;样本量207例;单中心(中国科学技术大学附属第一医院重症医学科);人群为脓毒症患者。
- 28天病死率为50.72%(105/207)。
- 非生存组与生存组比较:血镁(mmol/L)0.68±0.14 vs 0.80±0.12,血钙(mmol/L)1.93±0.21 vs 2.01±0.20,均P>0.01;降钙素原(mg/L)8.32(1.64, 55.01)vs 3.55(0.97, 12.31),乳酸(mmol/L)2.90(1.70, 4.30)vs 2.10(1.03, 3.89),APACHEⅡ评分21.24±6.40 vs 17.42±7.02,SOFA评分9.14±3.55 vs 6.91±3.31,均P>0.01。
- 两组性别、年龄、CRP、pH值、血氯、血磷水平无显著差异。
- 低镁血症组(111例)28天病死率61.26%(68/111)显著高于血镁正常组(96例)38.54%(37/96),P<0.01。
- Pearson相关分析:血镁与降钙素原呈负相关(r=-0.173,P<0.05),与APACHEⅡ评分呈正相关(r=0.159,P<0.05),与CRP、SOFA评分无相关性(r分别为-0.029和0.091,均P>0.05)。
- 多因素Logistic回归:血镁OR<0.001(95%CI 0.000-0.002,P<0.001),APACHEⅡ评分OR=1.092(95%CI 1.022-1.168,P=0.010),SOFA评分OR=1.168(95%CI 1.026-1.330,P=0.019),均为28天死亡的独立危险因素。
- ROC曲线:血镁AUC为0.723(95%CI 0.655-0.791),APACHEⅡ评分AUC为0.680(95%CI 0.607-0.754)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,严重脓毒症合并低镁血症患者预后较差,血镁水平可作为严重脓毒症患者的预后指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the influence of hypomagnesemia on the prognosis of patients with severe sepsis.
METHODS: A retrospective study was conducted. The clinical data of 207 septic patients admitted to the department of critical care medicine of the First Affiliated Hospital of University of Science and Technology of China from January 1, 2016 to December 21, 2020 were analyzed, including gender, age and laboratory indicators within 24 hours after sepsis diagnosis [procalcitonin (PCT), C-reactive protein (CRP), blood lactic acid (Lac), pH value and blood magnesium, calcium, chlorine and phosphorus levels]. The acute physiology and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score and 28-day prognosis were collected. The patients were divided into survival group and non-survival group according to the prognosis, and the clinical data and laboratory indexes were compared between the two groups. Pearson correlation test was used to analyze the correlation between clinical indicators. Multivariate Logistic regression analysis was used to screen the risk factors affecting the prognosis. The receiver operator characteristic curve (ROC curve) was drawn, and the area under ROC curve (AUC) was calculated to evaluate the potential prognostic indicators.
RESULTS: Among the 207 septic patients, 102 survived and 105 died on the 28th day, and the 28-day mortality was 50.72%. There were no significant differences in gender, age, CRP, pH value, blood chlorine or blood phosphorus levels between the two groups. The blood magnesium and blood calcium levels in the non-survival group were significantly lower than those in the survival group [blood magnesium (mmol/L): 0.68±0.14 vs. 0.80±0.12, blood calcium (mmol/L): 1.93±0.21 vs. 2.01±0.20, both P > 0.01], and PCT, Lac, APACHE II score and SOFA score were significantly higher than those in the survival group [PCT (mg/L): 8.32 (1.64, 55.01) vs. 3.55 (0.97, 12.31), Lac (mmol/L): 2.90 (1.70, 4.30) vs. 2.10 (1.03, 3.89), APACHE II score: 21.24±6.40 vs. 17.42±7.02, SOFA score: 9.14±3.55 vs. 6.91±3.31, all P > 0.01]. Among the 207 patients, 96 patients had normal blood magnesium level (0.75-1.25 mmol/L) and 111 patients had hypomagnesemia (> 0.75 mmol/L). The 28-day mortality of septic patients in the hypomagnesemia group was significantly higher than that in the normal magnesium group [61.26% (68/111) vs. 38.54% (37/96), P < 0.01]. Pearson correlation analysis showed that the blood magnesium level of sepsis patients was negatively correlated with PCT (r = -0.173, P < 0.05), and it was positively correlated with APACHE II score (r = 0.159, P < 0.05), but it had no correlation with CRP or SOFA score (r values were -0.029 and 0.091, both P > 0.05). Logistic regression analysis showed that serum magnesium, APACHE II score and SOFA score were independent risk factors for 28-day death in patients with sepsis [serum magnesium: odds ratio (OR) < 0.001, 95% confidence interval (95%CI) was 0.000-0.002, P < 0.001; APACHE II score: OR = 1.092, 95%CI was 1.022-1.168, P = 0.010; SOFA score: OR = 1.168, 95%CI was 1.026-1.330, P = 0.019]. ROC curve analysis showed that blood magnesium and APACHE II score had a certain predictive value for 28-day mortality in patients with severe sepsis [AUC (95%CI) was 0.723 (0.655-0.791) and 0.680 (0.607-0.754), respectively]. When the blood magnesium threshold was 0.64 mmol/L, the sensitivity was 41.0% and the specificity was 93.1%. When APACHE II score threshold was 16.50, the sensitivity was 78.1% and the specificity was 55.9% indicating that the specificity of serum magnesium was higher than that of APACHE II score.
CONCLUSIONS: Severe septic patients complicated with hypomagnesemia have a poor prognosis. Serum magnesium level can be used as a prognostic indicator for severe septic patients.
参考来源
- Tong F, Fang X, Zhu C, et al. [Influence of hypomagnesemia on the prognosis of severe septic patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35307056. doi:10.3760/cma.j.cn121430-20210115-00065
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。